Esteé Lauder Executive's Death Exposes Hidden Risks of Cosmetic Fillers

Kendal Ascher, a long-serving Estée Lauder executive, died in February from acute respiratory failure. The cause was a pulmonary embolism linked to cosmetic filler injections. His death was ruled an accident. Ascher spent 25 years at Estée Lauder, starting as a field account executive. He later became vice president of marketing before rising to senior vice president of the luxury portfolio. In this role, he managed high-end brands like La Mer and Tom Ford Beauty.

Under his leadership, La Mer grew into the world’s leading luxury skincare brand. His career was marked by significant achievements in the beauty industry.

Soft tissue filler injections were widely popular by 2014, with over 5.5 million procedures performed globally. Hyaluronic acid fillers alone were used in more than 800,000 treatments in the US each year. However, experts warn that certain facial areas, such as the pyriform fossa and the '11 lines' on the forehead, carry higher risks of complications.

Dr. Elizabeth Zeitler of BZ Dermatology noted that pulmonary embolism from fillers is rare. Dr. Alan Matarasso of the American Society of Plastic Surgeons stressed the importance of using certified professionals to reduce risks. Ascher’s death highlights the potential dangers of cosmetic procedures, even when performed by professionals. The incident underscores the need for caution and expertise in administering facial fillers.